EUVIMEDEUVIMED entdecken
Open Access

Macular Telangiectasia Type 2: Long-Term Disease Progression and Management of Complications

Merve Özbek iD, Özgür Artunay iD, Rümeysa Koçak iD, İlker Hoşver iD, Metehan Şimşek iD

Turkish Journal of Ophthalmology · 2025

DOI: 10.4274/tjo.galenos.2025.19940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Ophthalmology, 2025. Verfasst von Merve Özbek und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Health Sciences Türkiye, Beyoğlu Göz Training and Research Hospital, Clinic of Ophthalmology, İstanbul, Türkiye. Hauptthemen laut MEDLINE: Visual Acuity, Retinal Telangiectasis, Macula Lutea, Disease Management. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the long-term progression of macular telangiectasia type 2 (MacTel) using a standardized classification system and to assess the incidence, progression, and management strategies of complications such as macular neovascularization (MNV) and macular hole (MH). Materials and Methods: This retrospective study analyzed the medical records of patients diagnosed with MacTel at a tertiary referral center in Türkiye from January 2004 to February 2025. Patients with a minimum follow-up of 3 years and no confounding macular pathologies were included. Data collection included best corrected visual acuity (BCVA), multimodal imaging (optical coherence tomography [OCT], fundus autofluorescence, fluorescein angiography), and demographic variables. Disease severity was classified using the MacTel Classification System developed by Chew et al. Longitudinal changes in BCVA and OCT parameters were statistically analyzed.

Results

A total of 184 eyes from 94 patients (mean age: 63.89±9.98 years; mean follow-up: 79.27±50.69 months) were included. A significant decline in BCVA was observed (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Visual AcuityRetinal TelangiectasisMacula LuteaDisease ManagementRetinal PerforationsHumansRetrospective StudiesFemaleMaleTomography, Optical CoherenceDisease ProgressionFluorescein AngiographyMiddle AgedFollow-Up StudiesAngiogenesis InhibitorsFundus OculiIntravitreal InjectionsTime FactorsAged

Stichwörter der Autor:innen

Macular telangiectasia type 2macular holemacular neovascularization

Substanzen

Angiogenesis Inhibitors

Autor:innen und Institutionen

  • University of Health Sciences Türkiye, Beyoğlu Göz Training and Research Hospital, Clinic of Ophthalmology, İstanbul, Türkiye.

ORCID-Profile: Merve Özbek, Özgür Artunay, Rümeysa Koçak, İlker Hoşver, Metehan Şimşek

Zitieren

APA

Özbek, M., Artunay, Ö., Koçak, R., Hoşver, İ., & Şimşek, M. (2025). Macular Telangiectasia Type 2: Long-Term Disease Progression and Management of Complications. Turkish Journal of Ophthalmology. https://doi.org/10.4274/tjo.galenos.2025.19940

Vancouver

Özbek M, Artunay Ö, Koçak R, Hoşver İ, Şimşek M. Macular Telangiectasia Type 2: Long-Term Disease Progression and Management of Complications. Turkish Journal of Ophthalmology. 2025. doi:10.4274/tjo.galenos.2025.19940

BibTeX
@article{zbek2025,
  author = {Özbek, Merve and Artunay, Özgür and Koçak, Rümeysa and Hoşver, İlker and Şimşek, Metehan},
  title = {Macular Telangiectasia Type 2: Long-Term Disease Progression and Management of Complications},
  journal = {Turkish Journal of Ophthalmology},
  year = {2025},
  doi = {10.4274/tjo.galenos.2025.19940}
}
Kostenlos starten →